Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Analysis of TPE Treatments With multiFiltratePRO

NCT: NCT06272084 · ACTIVE_NOT_RECRUITING

NCT IDNCT06272084
StatusACTIVE_NOT_RECRUITING
Start Date2024-05-22
Completion2026-12
SponsorFresenius Medical Care Deutschland GmbH (INDUSTRY)
First posted
Last updated

Brief Summary

Analysis of therapeutic plasma exchange (TPE) treatments to assess the performance of the TPE mode of multiFiltratePRO based on the successful exchange of plasma from whole blood. The multiFiltratePRO is a device for extracorporeal blood purification treatments.

Frequently Asked Questions

What is Analysis of TPE Treatments With multiFiltratePRO?

Analysis of TPE Treatments With multiFiltratePRO is a clinical trial registered under NCT06272084. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06272084?

The current status of NCT06272084 (Analysis of TPE Treatments With multiFiltratePRO) is: ACTIVE_NOT_RECRUITING.

When did Analysis of TPE Treatments With multiFiltratePRO start?

Analysis of TPE Treatments With multiFiltratePRO started on 2024-05-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑